Biopharma Stocks Surge in a Seemingly Random Rally But Still Trail the S&P 500…Update-Risk Off
8/5... Risk OFF with Trade War and a Currency War XBI down 3.33% to $81.22, IBB down 2.65% to $102.29. WE will update later this week. Tuesday 8/6 we will attend the AACC Clinical EXPO in Anaheim CA. ======== Update-2..8/1 1:30p VRTX sparks biopharma stocks up 6% on earnings revenue...
Rayno BioBeat #1 2019: Biotech Trading Trends In a Choppy Market: Mid Year… Update-3. BIIB IWM
Update -3 ...Nice biotech rally today; green screen in gene therapy and mid-cap sectors. XBI and IWM up over 1%. Update-2...Small cap reversal IWM up 1.67% to $157 level; our small cap portfolio winners: AMRN CFMS GNMK MGTX VCEL etc. but XBI still lags stuck at $85 level. Gold and silver miners...
Can More Deals Wake Up Biotech? Laggard GILD Up 2.5% on More Galapagos Investment…Update-2 SGEN
Update-2 11:30a EDT Seattle Genetics (SGEN) revenues grow 30% , stock soars 15%.This is the way large cap biotech model is supposed to work-grow top line revenue.The Company is a leader in oncology with antibody-drug conjugates (ADC). ===== Update-1 Biopharma stocks drifted lower with NASDAQ:...
Vacation Week Update-Biotech Stocks…Update-1 IBB,ILMN
Update-1 11a EDT, Large cap drugs and biotechs resume slide on drug pricing "reform" from Trump threats. IBB down 1.37%, XPH in downtrend tp $38.41. Laggards holding BIB, GILD. Winners losing MRK, RHHBY. LLY and PFE hit hard. Gene therapy green: BOLD,SGMO. Illumina (ILMN) whacked over 15% on...
Gene Therapy Stocks are Big Winners in 2019: VYGR, MGTX, QURE… Update-1
Update-1 A bit of a sell-off in gene therapy but MGTX at new highs at $29.44. Profit taking on Sarepta down 3.84% to $150.59. Roche (RHHBY) and Merck (MRK) near new highs. Mid-caps mixed but Novacure (NVCR) rally 3.27% toward new highs. One of our top picks Amarin (AMRN) from the JPMorgan...